Initiation of c-ART in HIV-1 infected patients is associated with a decrease of the metabolic activity of the thymus evaluated using FDG-PET/computed tomography

Journal of Acquired Immune Deficiency Syndromes

Volumn 61, Issue 1, 2012, Pages 56-63

  Lelièvre, Jean Daniel ^a,b,c   Melica, Giovanna ^b,c   Itti, Emmanuel ^b,c   Lacabaratz, Christine ^a,b   Rozlan, Sandra ^d   Wiedemann, Aurélie ^a,b   Cheynier, Rémi ^d   Meignan, Michel ^b,c   Thiebaut, Rodolphe ^e,f   Levy, Yves ^a,b,c  

^a INSERM U955   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d INSTITUT PASTEUR   (France)

^e INSERM   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

FDG PET computed tomography; HIV 1; IL 7; T cell activation; thymus; TREC

Indexed keywords

ANTIRETROVIRUS AGENT; FLUORODEOXYGLUCOSE F 18; INTERLEUKIN 7; MOLECULAR MARKER; T LYMPHOCYTE RECEPTOR;

ARTICLE; CD4+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LYMPH NODE; LYMPHOCYTE ACTIVATION; PHENOTYPE; PLASMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYMUS;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HIV-1; HUMANS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; T-LYMPHOCYTES; THYMUS GLAND;

EID: 84865793637     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182615b62     Document Type: Article

References (52)

1. Mackall CL, Hakim FT, Gress RE. Restoration of T-cell homeostasis after T-cell depletion. Semin Immunol. 1997;9:339-346.
2. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995;332:143-149.
3. Fry TJ, Connick E, Falloon J, et al. A potential role for interleukin-7 in T-cell homeostasis. Blood. 2001;97:2983-2990.
4. Baskin GB, Murphey-Corb M, Martin LN, et al. Thymus in simian immunodeficiency virus-infected rhesus monkeys. Lab Invest. 1991;65: 400-407.
5. Joshi VV, Oleske JM, Saad S, et al. Thymus biopsy in children with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1986;110:837-842.
6. Dion ML, Poulin JF, Bordi R, et al. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity. 2004;21:757-768.
7. Franco JM, Rubio A, Martinez-Moya M, et al. T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood. 2002;99:3702-3706.
8. Hardy G, Worrell S, Hayes P, et al. Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection. HIV Med. 2004;5:67-73.
9. Markert ML, Alvarez-McLeod AP, Sempowski GD, et al. Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2001;17:1635-1643.
10. + T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection. Blood. 2007;109:2912-2920.
11. Harris JM, Hazenberg MD, Poulin JF, et al. Multiparameter evaluation of human thymic function: interpretations and caveats. Clin Immunol. 2005; 115:138-146.
12. Hazenberg MD, Verschuren MC, Hamann D, et al. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med. 2001;79:631-640.
13. Hazenberg MD, Otto SA, Cohen Stuart JW, et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med. 2000;6:1036-1042.
14. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396: 690-695.
15. von Boehmer H. Immunology. Thoracic thymus, exclusive no longer. Science. 2006;312:206-207.
16. Bains I, Thiebaut R, Yates AJ, et al. Quantifying thymic export: combining models of naive T cell proliferation and TCR excision circle dynamics gives an explicit measure of thymic output. J Immunol. 2009;183: 4329-4336.
17. + T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function. J Exp Med. 2009;206:275-285.
18. + T-cell subsets. Blood. 2009;113:769-774.
19. Meignan M, Haioun C, Itti E, et al. Value of [18F] fluorodeoxyglucosepositron emission tomography in managing patients with aggressive non-Hodgkin's lymphoma. Clin Lymphoma Myeloma. 2006;6:306-313.
20. Dion ML, Sekaly RP, Cheynier R. Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol. 2007;380:197-213.
21. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141-155.
22. Magri M, Yatim A, Benne C, et al. Notch ligands potentiate IL-7-driven proliferation and survival of human thymocyte precursors. Eur J Immunol. 2009;39:1231-1240.
23. Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev. 1997;160:91-102.
24. Napolitano LA, Schmidt D, Gotway MB, et al. Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest. 2008;118: 1085-1098.
25. Haynes BF, Hale LP, Weinhold KJ, et al. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest. 1999; 103:453-460.
26. Brink I, Reinhardt MJ, Hoegerle S, et al. Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med. 2001;42:591-595.
27. Levine JM, Weiner M, Kelly KM. Routine use of PET scans after completion of therapy in pediatric Hodgkin disease results in a high false positive rate. J Pediatr Hematol Oncol. 2006;28:711-714.
28. Patel PM, Alibazoglu H, Ali A, et al. Normal thymic uptake of FDG on PET imaging. Clin Nucl Med. 1996;21:772-775.
29. Smith CS, Schoder H, Yeung HW. Thymic extension in the superior mediastinum in patients with thymic hyperplasia: potential cause of false-positive findings on 18F-FDG PET/CT. AJR Am J Roentgenol. 2007;188:1716-1721.
30. Iyengar S, Chin B, Margolick JB, et al. Anatomical loci of HIV-associated immune activation and association with viraemia. Lancet. 2003;362: 945-950.
31. Love C, Tomas MB, Tronco GG, et al. FDG PET of infection and inflammation. Radiographics. 2005;25:1357-1368.
32. Lucignani G, Orunesu E, Cesari M, et al. FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imaging. 2009;36:640-647.
33. Sathekge M, Goethals I, Maes A, et al. Positron emission tomography in patients suffering from HIV-1 infection. Eur J Nucl Med Mol Imaging. 2009;36:1176-1184.
34. Sathekge M, Maes A, Kgomo M, et al. Fluorodeoxyglucose uptake by lymph nodes of HIV patients is inversely related to CD4 cell count. Nucl Med Commun. 2010;31:137-140.
35. Scharko AM, Perlman SB, Hinds PW, et al. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Natl Acad Sci USA. 1996;93:6425-6430.
36. Scharko AM, Perlman SB, Pyzalski RW, et al. Whole-body positron emission tomography in patients with HIV-1 infection. Lancet. 2003; 362:959-961.
37. Lee SM, Buchler T, Bomanji J, et al. Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult. AIDS. 2008;22:159-160.
38. Wallace M, Pyzalski R, Horejsh D, et al. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simianhuman immunodeficiency virus 89.6PD infection in rhesus macaques. Virology. 2000;274:255-261.
39. Brust D, Polis M, Davey R, et al. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. AIDS. 2006;20:495-503.
40. Agus DB, Surh CD, Sprent J. Reentry of T cells to the adult thymus is restricted to activated T cells. J Exp Med. 1991;173:1039-1046.
41. Lelievre JD, Levy Y. Perspectives on interleukin-7 therapy in HIV infection. Curr Opin HIV AIDS. 2007;2:228-233.
42. + T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008;197:126-133.
43. + T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis. 2003;187:1534-1543.
44. Lane HC, Masur H, Edgar LC, et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983;309:453-458.
45. + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:83-92.
46. Perry M, Whyte A. Immunology of the tonsils. Immunol Today. 1998;19: 414-421.
47. Ho Tsong Fang R, Colantonio AD, Uittenbogaart CH. The role of the thymus in HIV infection: a 10 year perspective. AIDS. 2008;22:171-184.
48. Grody WW, Fligiel S, Naeim F. Thymus involution in the acquired immunodeficiency syndrome. Am J Clin Pathol. 1985;84:85-95.
49. + T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals. PLoS One. 2010;5:e10788.
50. Li T, Wu N, Dai Y, et al. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy. Clin Infect Dis. 2011;53:944-951.
51. Tanaskovic S, Fernandez S, French MA, et al. Thymic tissue is not evident on high-resolution computed tomography and [(1)F]fluoro-deoxy-glucose positron emission tomography scans of aviraemic HIV patients with poor recovery of CD4 T cells. AIDS. 2011;25:1235-1237.
52. Levy Y, Lacabaratz C, Weiss L, et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest. 2009;119:997-1007.